3626:TSETIS Inc. Analysis
Data as of 2026-06-17 - not real-time
¥3,120.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
TIS Inc. (3626.T) is currently trading at ¥3,120, well below its 20‑day (¥3,348) and 50‑day (¥3,445) simple moving averages, indicating a short‑term bearish bias. The 14‑day RSI sits at 37.8, flirting with oversold territory but not yet triggering a reversal signal. A bearish MACD crossover (line –92.2 vs signal –63.1) and a widening negative histogram reinforce the downtrend. Volume has been tapering, and the 30‑day volatility is elevated at roughly 44%, suggesting price swings may remain pronounced. Nonetheless, the broader market mood is one of Extreme Greed (Fear‑Greed Index 88.5), which could provide a tailwind for risk‑on assets like Japanese tech stocks.
Fundamentally, TIS appears substantially undervalued: its trailing PE of 15.2 is far below the industry average of 37, and the discounted cash‑flow model pegs a fair value near ¥3,807, implying roughly 27% upside. The company delivers solid profitability with a 7.8% net margin, 14% ROE and 8.6% ROA, while maintaining a low debt‑to‑equity ratio (≈11%) and a cash pile of ¥97.5 bn. Revenue is growing modestly at 3.3% YoY, and forward EPS expectations lift the forward PE to 13.4, hinting at continued earnings momentum. Dividend sustainability looks robust, with a 2.88% yield, a payout ratio under 40%, and ample operating cash flow. Given the blend of attractive valuation, strong cash generation, and modest leverage, the stock presents a compelling value case despite its near‑term technical weakness.
Fundamentally, TIS appears substantially undervalued: its trailing PE of 15.2 is far below the industry average of 37, and the discounted cash‑flow model pegs a fair value near ¥3,807, implying roughly 27% upside. The company delivers solid profitability with a 7.8% net margin, 14% ROE and 8.6% ROA, while maintaining a low debt‑to‑equity ratio (≈11%) and a cash pile of ¥97.5 bn. Revenue is growing modestly at 3.3% YoY, and forward EPS expectations lift the forward PE to 13.4, hinting at continued earnings momentum. Dividend sustainability looks robust, with a 2.88% yield, a payout ratio under 40%, and ample operating cash flow. Given the blend of attractive valuation, strong cash generation, and modest leverage, the stock presents a compelling value case despite its near‑term technical weakness.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bearish technical indicators (price below SMA, negative MACD)
- Proximity to recent support level around ¥3,084
- Elevated 30‑day volatility (~44%)
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF‑derived fair value suggests ~27% upside
- Strong cash flow and low leverage
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Consistently low PE relative to industry
- Stable earnings growth and ROE ~14%
- Long‑term dividend sustainability and cash generation
Key Metrics & Analysis
Financial Health
Revenue Growth3.30%
Profit Margin7.82%
P/E Ratio15.2
ROE14.01%
ROA8.59%
Debt/Equity11.32
P/B Ratio2.1
Op. Cash Flow¥81.4B
Free Cash Flow¥48.3B
Industry P/E37.0
Technical Analysis
TrendBearish
RSI37.8
Support¥3,084.00
Resistance¥3,650.00
MA 20¥3,348.15
MA 50¥3,445.02
MA 200¥4,294.43
MACDBearish
VolumeDecreasing
Fear & Greed Index88.5
Valuation
Fair Value¥3,807.04
Target Price¥3,954.17
Upside/Downside26.74%
GradeUndervalued
TypeValue
Dividend Yield2.88%
Risk Assessment
Beta0.55
Volatility44.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.